Children with Canavan Disease receiving gene therapy in trial
Hear from one of the first families with a child to receive gene therapy for Canavan Disease as part of the CANaspire clinical trial by Aspa Therapeutics, a BridgeBio company.
Hear from one of the first families with a child to receive gene therapy for Canavan Disease as part of the CANaspire clinical trial by Aspa Therapeutics, a BridgeBio company.